Stockscreener 앱 받기
24.04
0.17%
0.04
시간 외 거래:
24.03
-0.010
-0.04%
전일 마감가:
$24.00
열려 있는:
$24.18
하루 거래량:
1.09M
Relative Volume:
1.04
시가총액:
$5.16B
수익:
$385.17M
순이익/손실:
$-316.92M
주가수익비율:
-15.51
EPS:
-1.55
순현금흐름:
$98.79M
1주 성능:
+1.43%
1개월 성능:
+9.12%
6개월 성능:
+75.47%
1년 성능:
+165.93%
1일 변동 폭
$23.78
$24.48
1주일 범위
$22.59
$24.62
52주 변동 폭
$8.91
$24.62
셀러브라이트 Stock (CLBT) Company Profile
CLBT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
24.04 | 5.16B | 385.17M | -316.92M | 98.79M | -1.55 |
|
MSFT
Microsoft Corporation
|
415.06 | 3.08T | 261.80B | 92.75B | 70.03B | 12.42 |
|
ORCL
Oracle Corp
|
170.06 | 471.25B | 54.93B | 11.63B | 9.54B | 4.09 |
|
ADBE
Adobe Inc
|
437.45 | 190.43B | 21.51B | 5.56B | 7.87B | 12.40 |
|
PLTR
Palantir Technologies Inc
|
82.49 | 187.91B | 2.65B | 476.57M | 980.32M | 0.20 |
|
CRWD
Crowdstrike Holdings Inc
|
398.07 | 98.05B | 3.74B | 126.71M | 1.10B | 0.51 |
셀러브라이트 Stock (CLBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-28 | 재확인 | Needham | Buy |
| 2024-03-13 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-07-19 | 개시 | Craig Hallum | Buy |
| 2022-08-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 개시 | Deutsche Bank | Buy |
| 2021-12-02 | 개시 | BofA Securities | Buy |
| 2021-10-21 | 개시 | Citigroup | Buy |
모두보기
셀러브라이트 주식(CLBT)의 최신 뉴스
Blue Trust Inc. Buys New Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Sets New 12-Month HighShould You Buy? - MarketBeat
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of “Buy” from Brokerages - Defense World
SG Americas Securities LLC Boosts Stake in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Sets New 1-Year High Following Analyst Upgrade - Defense World
Cellebrite DI (NASDAQ:CLBT) Hits New 52-Week High Following Analyst Upgrade - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Price Target Raised to $28.00 at Needham & Company LLC - MarketBeat
Jackson Square Capital LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 13.6% - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Reaches New 52-Week HighTime to Buy? - MarketBeat
JPMorgan Chase & Co. Purchases 75,092 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
JPMorgan Chase & Co. Grows Stake in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025 - GlobeNewswire
Cellebrite to Report Q4 and Full Year 2024 Financial Results on February 13 - StockTitan
Cellebrite Di Ltd (CLBT-Q) QuotePress Release - The Globe and Mail
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference - GlobeNewswire
Cellebrite to Present at Needham Growth Conference, CFO Dana Gerner to Lead Fireside Chat - StockTitan
Cellebrite Appoints Board Chair, Lead Independent Director - Law360
Analysts Set Cellebrite DI Ltd. (NASDAQ:CLBT) PT at $20.57 - MarketBeat
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of “Buy” from Brokerages - Defense World
Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director - GlobeNewswire
Cellebrite Strengthens Leadership: Tech Veteran Michael Capellas Joins Board, Hogan Named Interim CEO - StockTitan
Geode Capital Management LLC Sells 3,029 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
State Street Corp Raises Position in Cellebrite DI Ltd. (NASDAQ:CLBT) - Defense World
State Street Corp Has $7.47 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Principal Financial Group Inc. Buys Shares of 1,389,654 Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Barclays PLC Acquires 59,395 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Reaches New 1-Year High – Time to Buy? - Defense World
Cellebrite DI (NASDAQ:CLBT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Cellebrite DILeader in Digital Forensics - TradingView
Serbia used Israeli firm’s tech to enable spy campaign, Amnesty says - MSN
Tidal Investments LLC Acquires 38,887 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) - MarketBeat
Amnesty International: Serbia Uses Israeli Technology To Spy On Activists And Journalists - VOI.ID
684,220 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Acquired by Lord Abbett & CO. LLC - MarketBeat
JPMorgan Chase & Co. Issues Positive Forecast for Cellebrite DI (NASDAQ:CLBT) Stock Price - Defense World
Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Down 17.1% in November - MarketBeat
Serbia spied on journalists: report - 台北時報
Serbia used Israeli phone-hacking tool to enable spy campaign – Amnesty report - The Times of Israel
Cellebrite DI (NASDAQ:CLBT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Serbia used spyware against activists and journalists, Amnesty says - TVP World
Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia - Insider Monkey
Amnesty accuses Serbia of using Israeli firm’s tech to enable spy campaign - The Arab Weekly
Amnesty: Serbia used an Israeli company's technology for an espionage campaign - Telegrafi
The Israeli company that supplied it with the spyware reacts to the scandal with the wiretapping in Serbia - A2 CNN
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Serbian spyware covertly monitors journalists, activists’ phones, Amnesty says - Cyprus Mail
Amnesty: Serbia used Israeli company's technology for espionage campaign - Vox News Albania
Amnesty: Serbia used Israeli spyware to hack phones of activists, journalists - The Jerusalem Post
셀러브라이트 (CLBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
0.83%
자본화:
|
볼륨(24시간):